Close Menu

NEW YORK (GenomeWeb) – Foundation Medicine said today that it is entering a strategic collaboration with Novartis focused on developing companion diagnostic tests for the company's portfolio of targeted oncology and immuno-oncology drugs.

According to Foundation, the collaboration structure includes development, regulatory support and commercialization of CDx tests using its US Food and Drug Administration-approved comprehensive genomic profiling assay, FoundationOne CDx.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers uncovered the HIV virus within a tissue sample collected in 1966, the Atlantic reports.

Nature News reports there are a handful of clinical trials underway to evaluate vaginal microbiome seeding of newborns born via caesarian section.

The Washington Post writes that humans may have contributed to the extinction of cave bears some 20,000 years ago.

In PLOS this week: gene variant may protect against trypanosomiasis, GLIS3 role in type 2 diabetes, and more.